Department of Radiology, New York University Langone Medical Center, New York, NY, USA.
Radiology. 2012 Nov;265(2):468-77. doi: 10.1148/radiol.12112087. Epub 2012 Sep 25.
To retrospectively assess whether magnetic resonance (MR) imaging with opposed-phase and in-phase gradient-echo (GRE) sequences and MR feature analysis can differentiate angiomyolipomas (AMLs) that contain minimal fat from clear cell renal cell carcinomas (RCCs), with particular emphasis on small (<3-cm) masses.
Institutional review board approval and a waiver of informed consent were obtained for this HIPAA-compliant study. MR images from 108 pathologically proved renal masses (88 clear cell RCCs and 20 minimal fat AMLs from 64 men and 44 women) at two academic institutions were evaluated. The signal intensity (SI) of each renal mass and spleen on opposed-phase and in-phase GRE images was used to calculate an SI index and tumor-to-spleen SI ratio. Two radiologists who were blinded to the pathologic results independently assessed the subjective presence of intravoxel fat (ie, decreased SI on opposed-phase images compared with that on in-phase images), SI on T1-weighted and T2-weighted images, cystic degeneration, necrosis, hemorrhage, retroperitoneal collaterals, and renal vein thrombosis. Results were analyzed by using the Wilcoxon rank sum test, two-tailed Fisher exact test, and multivariate logistic regression analysis for all renal masses and for small masses. A P value of less than .05 was considered to indicate a statistically significant difference.
There were no differences between minimal fat AMLs and clear cell RCCs for the SI index (8.05%±14.46 vs 14.99%±19.9; P=.146) or tumor-to-spleen ratio (-8.96%±16.6 and -15.8%±22.4; P=.227) when all masses or small masses were analyzed. Diagnostic accuracy (area under receiver operating characteristic curve) for the SI index and tumor-to-spleen ratio was 0.59. Intratumoral necrosis and larger size were predictive of clear cell RCC (P<.001) for all lesions, whereas low SI (relative to renal parenchyma SI) on T2-weighted images, smaller size, and female sex correlated with minimal fat AML (P<.001) for all lesions.
The diagnostic accuracy of opposed-phase and in-phase GRE MR imaging for the differentiation of minimal fat AML and clear cell RCC is poor. In this cohort, low SI on T2-weighted images relative to renal parenchyma and small size suggested minimal fat AML, whereas intratumoral necrosis and large size argued against this diagnosis.
回顾性评估磁共振(MR)成像的反相位和同相位梯度回波(GRE)序列以及 MR 特征分析是否可以区分含有最小脂肪的血管平滑肌脂肪瘤(AML)与透明细胞肾细胞癌(RCC),特别强调小(<3cm)肿块。
本 HIPAA 合规研究获得了机构审查委员会的批准和知情同意豁免。对来自两个学术机构的 108 例经病理证实的肾脏肿块(64 名男性和 44 名女性的 88 例透明细胞 RCC 和 20 例最小脂肪 AML)的 MR 图像进行了评估。使用每个肾脏肿块和脾脏的反相位和同相位 GRE 图像的信号强度(SI)来计算 SI 指数和肿瘤与脾脏的 SI 比值。两位放射科医生在不知道病理结果的情况下独立评估了局灶性脂肪的存在(即,与同相位图像相比,反相位图像上的 SI 降低)、T1 加权和 T2 加权图像上的 SI、囊性变性、坏死、出血、腹膜后侧支循环和肾静脉血栓形成。使用 Wilcoxon 秩和检验、双侧 Fisher 确切检验和多变量逻辑回归分析对所有肾脏肿块和小肿块进行了分析。P 值小于 0.05 被认为具有统计学意义。
在分析所有肿块和小肿块时,最小脂肪 AML 和透明细胞 RCC 的 SI 指数(8.05%±14.46 与 14.99%±19.9;P=.146)或肿瘤与脾脏的比值(-8.96%±16.6 和-15.8%±22.4;P=.227)均无差异。SI 指数和肿瘤与脾脏比值的诊断准确性(受试者工作特征曲线下面积)为 0.59。肿瘤内坏死和较大的大小与透明细胞 RCC 相关(P<.001),适用于所有病变,而 T2 加权图像上的低 SI(相对于肾实质 SI)、较小的大小和女性与最小脂肪 AML 相关(P<.001),适用于所有病变。
反相位和同相位 GRE MR 成像对最小脂肪 AML 和透明细胞 RCC 的鉴别诊断准确性较差。在本队列中,相对于肾实质的 T2 加权图像上的低 SI 和较小的大小提示最小脂肪 AML,而肿瘤内坏死和较大的大小则反对这一诊断。